CASI PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
CASI PHARMACEUTICALS, INC. (CASIF) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 1.00 million shares as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-05-15
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.00M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.98M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 617.28K shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 617.28K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2025-12-31 | 1.00M shares 20-F · filed 2026-05-15 |
| 2024-12-31 | 1.98M shares 20-F · filed 2026-05-15 |
| 2022-12-31 | 617.28K shares 20-F · filed 2025-03-31 |
| 2021-12-31 | 617.28K shares 20-F · filed 2024-03-28 |
| 2020-12-31 | 827.16K shares 20-F · filed 2024-03-28 |
| 2019-12-31 | 984.36K shares 20-F · filed 2023-04-26 |